NCT02003222 · FLOW
Participant flow
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- groups
- description
- MRD negative patients received induction treatment and intensification treatment and then were randomized to receive blinatumomab plus chemotherapy.
- id
- FG000
- title
- MRD Negative - Blinatumomab + Chemotherapy
- description
- MRD negative patients received induction treatment and intensification treatment and then were randomized to receive chemotherapy.
- id
- FG001
- title
- MRD Negative - Chemotherapy
- description
- MRD positive patients received induction treatment and intensification treatment and then were randomized or assigned to receive blinatumomab plus chemotherapy.
- id
- FG002
- title
- MRD Positive - Blinatumomab + Chemotherapy
- description
- MRD positive patients received induction treatment and intensification treatment and then were randomized to receive chemotherapy.
- id
- FG003
- title
- MRD Positive - Chemotherapy
- description
- Patients were registered to receive induction treatment and intensification treatment but did not enter the randomization part of the study.
- id
- FG004
- title
- No Randomization/Registration
- periods
- drop Withdraws
- reasons
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 0
- group Id
- FG002
- num Subjects
- 0
- group Id
- FG003
- num Subjects
- 0
- group Id
- FG004
- num Subjects
- 8
- type
- Never started treatment
- reasons
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 0
- group Id
- FG002
- num Subjects
- 0
- group Id
- FG003
- num Subjects
- 0
- group Id
- FG004
- num Subjects
- 67
- type
- Complete remission or complete remission incomplete not achieved
- reasons
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 0
- group Id
- FG002
- num Subjects
- 0
- group Id
- FG003
- num Subjects
- 0
- group Id
- FG004
- num Subjects
- 13
- type
- Adverse Event
- reasons
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 0
- group Id
- FG002
- num Subjects
- 0
- group Id
- FG003
- num Subjects
- 0
- group Id
- FG004
- num Subjects
- 12
- type
- Alternative therapy
- reasons
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 0
- group Id
- FG002
- num Subjects
- 0
- group Id
- FG003
- num Subjects
- 0
- group Id
- FG004
- num Subjects
- 22
- type
- Disease progression
- reasons
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 0
- group Id
- FG002
- num Subjects
- 0
- group Id
- FG003
- num Subjects
- 0
- group Id
- FG004
- num Subjects
- 3
- type
- Death
- reasons
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 0
- group Id
- FG002
- num Subjects
- 0
- group Id
- FG003
- num Subjects
- 0
- group Id
- FG004
- num Subjects
- 8
- type
- Withdrawal by Subject
- reasons
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 0
- group Id
- FG002
- num Subjects
- 0
- group Id
- FG003
- num Subjects
- 0
- group Id
- FG004
- num Subjects
- 22
- type
- Other reasons
- milestones
- achievements
- group Id
- FG000
- num Subjects
- 112
- group Id
- FG001
- num Subjects
- 112
- group Id
- FG002
- num Subjects
- 40
- group Id
- FG003
- num Subjects
- 22
- group Id
- FG004
- num Subjects
- 202
- type
- STARTED
- achievements
- group Id
- FG000
- num Subjects
- 112
- group Id
- FG001
- num Subjects
- 112
- group Id
- FG002
- num Subjects
- 40
- group Id
- FG003
- num Subjects
- 22
- group Id
- FG004
- num Subjects
- 193
- type
- Received Treatment and Adverse Event Assessment Available
- achievements
- group Id
- FG000
- num Subjects
- 112
- group Id
- FG001
- num Subjects
- 112
- group Id
- FG002
- num Subjects
- 40
- group Id
- FG003
- num Subjects
- 22
- group Id
- FG004
- num Subjects
- 47
- type
- COMPLETED
- achievements
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 0
- group Id
- FG002
- num Subjects
- 0
- group Id
- FG003
- num Subjects
- 0
- group Id
- FG004
- num Subjects
- 155
- type
- NOT COMPLETED
- title
- Induction
- drop Withdraws
- reasons
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 0
- group Id
- FG002
- num Subjects
- 0
- group Id
- FG003
- num Subjects
- 0
- group Id
- FG004
- num Subjects
- 2
- type
- Never started treatment
- reasons
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 0
- group Id
- FG002
- num Subjects
- 0
- group Id
- FG003
- num Subjects
- 0
- group Id
- FG004
- num Subjects
- 6
- type
- Adverse Event
- reasons
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 0
- group Id
- FG002
- num Subjects
- 0
- group Id
- FG003
- num Subjects
- 0
- group Id
- FG004
- num Subjects
- 8
- type
- Alternative therapy
- reasons
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 0
- group Id
- FG002
- num Subjects
- 0
- group Id
- FG003
- num Subjects
- 0
- group Id
- FG004
- num Subjects
- 18
- type
- Disease progression
- reasons
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 0
- group Id
- FG002
- num Subjects
- 0
- group Id
- FG003
- num Subjects
- 0
- group Id
- FG004
- num Subjects
- 5
- type
- Withdrawal by Subject
- reasons
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 0
- group Id
- FG002
- num Subjects
- 0
- group Id
- FG003
- num Subjects
- 0
- group Id
- FG004
- num Subjects
- 8
- type
- Other reasons
- milestones
- achievements
- group Id
- FG000
- num Subjects
- 112
- group Id
- FG001
- num Subjects
- 112
- group Id
- FG002
- num Subjects
- 40
- group Id
- FG003
- num Subjects
- 22
- group Id
- FG004
- num Subjects
- 47
- type
- STARTED
- achievements
- group Id
- FG000
- num Subjects
- 112
- group Id
- FG001
- num Subjects
- 112
- group Id
- FG002
- num Subjects
- 40
- group Id
- FG003
- num Subjects
- 22
- group Id
- FG004
- num Subjects
- 30
- type
- Received Treatment and Adverse Event Assessment Available
- achievements
- group Id
- FG000
- num Subjects
- 112
- group Id
- FG001
- num Subjects
- 112
- group Id
- FG002
- num Subjects
- 40
- group Id
- FG003
- num Subjects
- 22
- group Id
- FG004
- num Subjects
- 0
- type
- COMPLETED
- achievements
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 0
- group Id
- FG002
- num Subjects
- 0
- group Id
- FG003
- num Subjects
- 0
- group Id
- FG004
- num Subjects
- 47
- type
- NOT COMPLETED
- title
- Intensification
- milestones
- achievements
- group Id
- FG000
- num Subjects
- 112
- group Id
- FG001
- num Subjects
- 112
- group Id
- FG002
- num Subjects
- 40
- group Id
- FG003
- num Subjects
- 22
- group Id
- FG004
- num Subjects
- 0
- type
- STARTED
- achievements
- group Id
- FG000
- num Subjects
- 111
- group Id
- FG001
- num Subjects
- 110
- group Id
- FG002
- num Subjects
- 35
- group Id
- FG003
- num Subjects
- 16
- group Id
- FG004
- num Subjects
- 0
- type
- Received Treatment and Adverse Event Assessment Available
- achievements
- group Id
- FG000
- num Subjects
- 112
- group Id
- FG001
- num Subjects
- 112
- group Id
- FG002
- num Subjects
- 40
- group Id
- FG003
- num Subjects
- 22
- group Id
- FG004
- num Subjects
- 0
- type
- COMPLETED
- achievements
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 0
- group Id
- FG002
- num Subjects
- 0
- group Id
- FG003
- num Subjects
- 0
- group Id
- FG004
- num Subjects
- 0
- type
- NOT COMPLETED
- title
- Randomization/Registration
- milestones
- achievements
- group Id
- FG000
- num Subjects
- 67
- group Id
- FG001
- num Subjects
- 69
- group Id
- FG002
- num Subjects
- 13
- group Id
- FG003
- num Subjects
- 2
- group Id
- FG004
- num Subjects
- 0
- type
- STARTED
- achievements
- group Id
- FG000
- num Subjects
- 66
- group Id
- FG001
- num Subjects
- 68
- group Id
- FG002
- num Subjects
- 12
- group Id
- FG003
- num Subjects
- 2
- group Id
- FG004
- num Subjects
- 0
- type
- Received Treatment and Adverse Event Assessment Available
- achievements
- group Id
- FG000
- num Subjects
- 67
- group Id
- FG001
- num Subjects
- 69
- group Id
- FG002
- num Subjects
- 13
- group Id
- FG003
- num Subjects
- 2
- group Id
- FG004
- num Subjects
- 0
- type
- COMPLETED
- achievements
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 0
- group Id
- FG002
- num Subjects
- 0
- group Id
- FG003
- num Subjects
- 0
- group Id
- FG004
- num Subjects
- 0
- type
- NOT COMPLETED
- title
- Maintenance
- recruitment Details
- This study was activated on December 17, 2013 and closed to accrual on October 15, 2019 after enrolling a total of 488 patients.
Complete source fields
- groups
- description
- MRD negative patients received induction treatment and intensification treatment and then were randomized to receive blinatumomab plus chemotherapy.
- id
- FG000
- title
- MRD Negative - Blinatumomab + Chemotherapy
- description
- MRD negative patients received induction treatment and intensification treatment and then were randomized to receive chemotherapy.
- id
- FG001
- title
- MRD Negative - Chemotherapy
- description
- MRD positive patients received induction treatment and intensification treatment and then were randomized or assigned to receive blinatumomab plus chemotherapy.
- id
- FG002
- title
- MRD Positive - Blinatumomab + Chemotherapy
- description
- MRD positive patients received induction treatment and intensification treatment and then were randomized to receive chemotherapy.
- id
- FG003
- title
- MRD Positive - Chemotherapy
- description
- Patients were registered to receive induction treatment and intensification treatment but did not enter the randomization part of the study.
- id
- FG004
- title
- No Randomization/Registration
- periods
- drop Withdraws
- reasons
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 0
- group Id
- FG002
- num Subjects
- 0
- group Id
- FG003
- num Subjects
- 0
- group Id
- FG004
- num Subjects
- 8
- type
- Never started treatment
- reasons
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 0
- group Id
- FG002
- num Subjects
- 0
- group Id
- FG003
- num Subjects
- 0
- group Id
- FG004
- num Subjects
- 67
- type
- Complete remission or complete remission incomplete not achieved
- reasons
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 0
- group Id
- FG002
- num Subjects
- 0
- group Id
- FG003
- num Subjects
- 0
- group Id
- FG004
- num Subjects
- 13
- type
- Adverse Event
- reasons
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 0
- group Id
- FG002
- num Subjects
- 0
- group Id
- FG003
- num Subjects
- 0
- group Id
- FG004
- num Subjects
- 12
- type
- Alternative therapy
- reasons
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 0
- group Id
- FG002
- num Subjects
- 0
- group Id
- FG003
- num Subjects
- 0
- group Id
- FG004
- num Subjects
- 22
- type
- Disease progression
- reasons
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 0
- group Id
- FG002
- num Subjects
- 0
- group Id
- FG003
- num Subjects
- 0
- group Id
- FG004
- num Subjects
- 3
- type
- Death
- reasons
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 0
- group Id
- FG002
- num Subjects
- 0
- group Id
- FG003
- num Subjects
- 0
- group Id
- FG004
- num Subjects
- 8
- type
- Withdrawal by Subject
- reasons
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 0
- group Id
- FG002
- num Subjects
- 0
- group Id
- FG003
- num Subjects
- 0
- group Id
- FG004
- num Subjects
- 22
- type
- Other reasons
- milestones
- achievements
- group Id
- FG000
- num Subjects
- 112
- group Id
- FG001
- num Subjects
- 112
- group Id
- FG002
- num Subjects
- 40
- group Id
- FG003
- num Subjects
- 22
- group Id
- FG004
- num Subjects
- 202
- type
- STARTED
- achievements
- group Id
- FG000
- num Subjects
- 112
- group Id
- FG001
- num Subjects
- 112
- group Id
- FG002
- num Subjects
- 40
- group Id
- FG003
- num Subjects
- 22
- group Id
- FG004
- num Subjects
- 193
- type
- Received Treatment and Adverse Event Assessment Available
- achievements
- group Id
- FG000
- num Subjects
- 112
- group Id
- FG001
- num Subjects
- 112
- group Id
- FG002
- num Subjects
- 40
- group Id
- FG003
- num Subjects
- 22
- group Id
- FG004
- num Subjects
- 47
- type
- COMPLETED
- achievements
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 0
- group Id
- FG002
- num Subjects
- 0
- group Id
- FG003
- num Subjects
- 0
- group Id
- FG004
- num Subjects
- 155
- type
- NOT COMPLETED
- title
- Induction
- drop Withdraws
- reasons
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 0
- group Id
- FG002
- num Subjects
- 0
- group Id
- FG003
- num Subjects
- 0
- group Id
- FG004
- num Subjects
- 2
- type
- Never started treatment
- reasons
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 0
- group Id
- FG002
- num Subjects
- 0
- group Id
- FG003
- num Subjects
- 0
- group Id
- FG004
- num Subjects
- 6
- type
- Adverse Event
- reasons
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 0
- group Id
- FG002
- num Subjects
- 0
- group Id
- FG003
- num Subjects
- 0
- group Id
- FG004
- num Subjects
- 8
- type
- Alternative therapy
- reasons
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 0
- group Id
- FG002
- num Subjects
- 0
- group Id
- FG003
- num Subjects
- 0
- group Id
- FG004
- num Subjects
- 18
- type
- Disease progression
- reasons
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 0
- group Id
- FG002
- num Subjects
- 0
- group Id
- FG003
- num Subjects
- 0
- group Id
- FG004
- num Subjects
- 5
- type
- Withdrawal by Subject
- reasons
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 0
- group Id
- FG002
- num Subjects
- 0
- group Id
- FG003
- num Subjects
- 0
- group Id
- FG004
- num Subjects
- 8
- type
- Other reasons
- milestones
- achievements
- group Id
- FG000
- num Subjects
- 112
- group Id
- FG001
- num Subjects
- 112
- group Id
- FG002
- num Subjects
- 40
- group Id
- FG003
- num Subjects
- 22
- group Id
- FG004
- num Subjects
- 47
- type
- STARTED
- achievements
- group Id
- FG000
- num Subjects
- 112
- group Id
- FG001
- num Subjects
- 112
- group Id
- FG002
- num Subjects
- 40
- group Id
- FG003
- num Subjects
- 22
- group Id
- FG004
- num Subjects
- 30
- type
- Received Treatment and Adverse Event Assessment Available
- achievements
- group Id
- FG000
- num Subjects
- 112
- group Id
- FG001
- num Subjects
- 112
- group Id
- FG002
- num Subjects
- 40
- group Id
- FG003
- num Subjects
- 22
- group Id
- FG004
- num Subjects
- 0
- type
- COMPLETED
- achievements
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 0
- group Id
- FG002
- num Subjects
- 0
- group Id
- FG003
- num Subjects
- 0
- group Id
- FG004
- num Subjects
- 47
- type
- NOT COMPLETED
- title
- Intensification
- milestones
- achievements
- group Id
- FG000
- num Subjects
- 112
- group Id
- FG001
- num Subjects
- 112
- group Id
- FG002
- num Subjects
- 40
- group Id
- FG003
- num Subjects
- 22
- group Id
- FG004
- num Subjects
- 0
- type
- STARTED
- achievements
- group Id
- FG000
- num Subjects
- 111
- group Id
- FG001
- num Subjects
- 110
- group Id
- FG002
- num Subjects
- 35
- group Id
- FG003
- num Subjects
- 16
- group Id
- FG004
- num Subjects
- 0
- type
- Received Treatment and Adverse Event Assessment Available
- achievements
- group Id
- FG000
- num Subjects
- 112
- group Id
- FG001
- num Subjects
- 112
- group Id
- FG002
- num Subjects
- 40
- group Id
- FG003
- num Subjects
- 22
- group Id
- FG004
- num Subjects
- 0
- type
- COMPLETED
- achievements
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 0
- group Id
- FG002
- num Subjects
- 0
- group Id
- FG003
- num Subjects
- 0
- group Id
- FG004
- num Subjects
- 0
- type
- NOT COMPLETED
- title
- Randomization/Registration
- milestones
- achievements
- group Id
- FG000
- num Subjects
- 67
- group Id
- FG001
- num Subjects
- 69
- group Id
- FG002
- num Subjects
- 13
- group Id
- FG003
- num Subjects
- 2
- group Id
- FG004
- num Subjects
- 0
- type
- STARTED
- achievements
- group Id
- FG000
- num Subjects
- 66
- group Id
- FG001
- num Subjects
- 68
- group Id
- FG002
- num Subjects
- 12
- group Id
- FG003
- num Subjects
- 2
- group Id
- FG004
- num Subjects
- 0
- type
- Received Treatment and Adverse Event Assessment Available
- achievements
- group Id
- FG000
- num Subjects
- 67
- group Id
- FG001
- num Subjects
- 69
- group Id
- FG002
- num Subjects
- 13
- group Id
- FG003
- num Subjects
- 2
- group Id
- FG004
- num Subjects
- 0
- type
- COMPLETED
- achievements
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 0
- group Id
- FG002
- num Subjects
- 0
- group Id
- FG003
- num Subjects
- 0
- group Id
- FG004
- num Subjects
- 0
- type
- NOT COMPLETED
- title
- Maintenance
- recruitment Details
- This study was activated on December 17, 2013 and closed to accrual on October 15, 2019 after enrolling a total of 488 patients.
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice
Triangle